Carbamazepine-Induced SIADH — RACP Adult Medicine MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: A — Carbamazepine-induced SIADH
Euvolaemic hyponatraemia with SIADH pattern (low serum osm, inappropriately concentrated urine, high urine Na⁺) on carbamazepine is drug-induced SIADH. Carbamazepine (and its derivative oxcarbazepine) stimulates ADH release and potentiates its action. Incidence is ~5-40% (more common with oxcarbazepine). Management: fluid restriction, reduce/switch antiepileptic if possible (levetiracetam, lamotrigine have lower risk).
Reference: AMH – 2025 – Carbamazepine; European Hyponatraemia Guidelines 2023